 - Subjects with evidence or history of clinically significant immunologic, hematologic, renal, endocrine, pulmonary, gastrointestinal, cardiovascular, hepatic, psychiatric, neurologic, or allergic disease including drug allergies, surgical conditions, cancer or any other condition that, in the Investigators opinion, might significantly interfere with the absorption, distribution, metabolism, or excretion of the study drug; 